Evaluation of risk factors and assessment models for predicting venous thromboembolism in lung cancer patients

J Rupa-Matysek, M Lembicz, EK Rogowska, L Gil… - Medical Oncology, 2018 - Springer
The aim of the study was to investigate the prognostic significance of selected risk
assessment models (RAMs) for predicting venous thromboembolism (VTE) events in …

COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment …

H Abdel-Razeq, B Sharaf, MJ Al-Jaghbeer… - Journal of Thrombosis …, 2023 - Springer
Cancer patients are at higher risk for venous thromboembolism (VTE). Several risk
assessment models (RAM), including the Khorana and COMPASS-CAT, were developed to …

Development and validation of a risk score for prediction of venous thromboembolism in patients with lung cancer

Z Li, G Zhang, M Zhang, J Mei… - Clinical and Applied …, 2020 - journals.sagepub.com
This study aimed to develop and validate a risk score for early prediction of venous
thromboembolism (VTE) in patients with lung cancer. A total of 827 patients with lung cancer …

Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer

W Xiong, Y Zhao, H Du, Y Wang, M Xu, X Guo - Thrombosis Journal, 2021 - Springer
Background Cancer-associated venous thromboembolism (VTE) is common in patients with
primary lung cancer. It has been understudied which authoritative risk assessment score of …

A new risk prediction model for venous thromboembolism and death in ambulatory lung cancer patients

P Gomez-Rosas, C Giaccherini, L Russo, C Verzeroli… - Cancers, 2023 - mdpi.com
Simple Summary The predictive value of existing venous thromboembolism risk assessment
models (RAMs) in lung cancer patients is still debated, and the design of new models …

A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study

Y Tsubata, T Hotta, K Hamai, N Furuya… - Journal of Hematology & …, 2022 - Springer
Management of cancer-associated venous thromboembolism (VTE) is essential in treatment
selection and cancer prognosis. However, to date, there is no method to assess the risk of …

Predictors of venous thromboembolism and early mortality in lung cancer: results from a global prospective study (CANTARISK)

NM Kuderer, MS Poniewierski, E Culakova… - The …, 2018 - academic.oup.com
Background Patients with lung cancer are known to be at increased risk for venous
thromboembolism (VTE). Venous thromboembolism is associated with increased risk for …

Derivation, validation and assessment of a novel nomogram-based risk assessment model for venous thromboembolism in hospitalized patients with lung cancer: a …

H Li, Y Tian, H Niu, L He, G Cao, C Zhang… - Frontiers in …, 2022 - frontiersin.org
Purpose This study aimed to develop and validate a specific risk-stratification nomogram
model for the prediction of venous thromboembolism (VTE) in hospitalized patients with lung …

Development and validation of a predictive score for venous thromboembolism in newly diagnosed non-small cell lung cancer

J Li, J Yi, L Hua, Y Su, M Huo, F Dou, Z Zhai, M Zhu… - Thrombosis …, 2021 - Elsevier
Introduction The risk of venous thromboembolism (VTE) varies among tumour types, and
different cancer type-specific risks for VTE prediction remain undefined. We aimed to …

External validation of a venous thromboembolic risk score for cancer outpatients with solid tumors: the COMPASS‐CAT venous thromboembolism risk assessment …

AC Spyropoulos, JB Eldredge, LN Anand… - The …, 2020 - academic.oup.com
Background Current risk assessment models (RAMs) for prediction of venous
thromboembolism (VTE) risk in the outpatient cancer population have shown poor predictive …